- In March 2023, In a significant partnership, Roche and Eli Lilly worked together to accelerate the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP). This collaboration aimed to support the expansion of innovative diagnostic solutions, specifically focused on Alzheimer’s disease. The Elecsys Amyloid Plasma Panel is designed to detect amyloid plaques in the brain through blood plasma, offering a less invasive and more accessible method of diagnosing Alzheimer's, compared to traditional imaging techniques
- In February 2023, bioMérieux, a global leader in in-vitro diagnostics, achieved a major milestone in February 2023 with the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) and the Clinical Laboratory Improvement Amendments (CLIA) waiver for their BIOFIRE SPOTFIRE system and BIOFIRE SPOTFIRE respiratory panel. This new system is designed to provide fast, accurate, and comprehensive testing for respiratory infections
- In February 2022, bioMérieux introduced VIDAS KUBE, an advanced automated system for immunoassay testing. The VIDAS KUBE system is designed to provide high-performance diagnostic solutions for laboratories, improving testing efficiency and accuracy. It offers a new level of automation and ease of use for immunoassays, contributing to better workflow and faster results
